Christopher R. Stone

Array ( [id] => 4813970 [patent_doc_number] => 20080194601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Prevention Of Hiv-Infection With Tmc278' [patent_app_type] => utility [patent_app_number] => 11/910034 [patent_app_country] => US [patent_app_date] => 2006-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6530 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194601.pdf [firstpage_image] =>[orig_patent_app_number] => 11910034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7692672 [patent_doc_number] => 20070231361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Use of Fatty Acids to Inhibit the Growth of Aneurysms' [patent_app_type] => utility [patent_app_number] => 11/277637 [patent_app_country] => US [patent_app_date] => 2006-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5979 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20070231361.pdf [firstpage_image] =>[orig_patent_app_number] => 11277637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887765 [patent_doc_number] => 20080262097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Formulations' [patent_app_type] => utility [patent_app_number] => 11/909066 [patent_app_country] => US [patent_app_date] => 2006-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16317 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262097.pdf [firstpage_image] =>[orig_patent_app_number] => 11909066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5693695 [patent_doc_number] => 20060153842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Immunosuppressive combination and its use in the treatment or prophylaxis or insulin-producing cell graft rejection' [patent_app_type] => utility [patent_app_number] => 11/372383 [patent_app_country] => US [patent_app_date] => 2006-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4703 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20060153842.pdf [firstpage_image] =>[orig_patent_app_number] => 11372383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5005655 [patent_doc_number] => 20070203227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Isoflavan and isoflavene compounds and their use as angiogenesis inhibitors' [patent_app_type] => utility [patent_app_number] => 11/361229 [patent_app_country] => US [patent_app_date] => 2006-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4456 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203227.pdf [firstpage_image] =>[orig_patent_app_number] => 11361229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8214282 [patent_doc_number] => 08193173 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'Liver function ameliorant' [patent_app_type] => utility [patent_app_number] => 11/628841 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 1793 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/193/08193173.pdf [firstpage_image] =>[orig_patent_app_number] => 11628841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4486518 [patent_doc_number] => 07884094 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-08 [patent_title] => 'Compounds for the treatment of proliferative disorders' [patent_app_type] => utility [patent_app_number] => 11/355922 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 23 [patent_no_of_words] => 59972 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/884/07884094.pdf [firstpage_image] =>[orig_patent_app_number] => 11355922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5331360 [patent_doc_number] => 20090111837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'USE OF PDE7 INHIBITORS FOR THE TREATMENT OF NEUROPATHIC PAIN' [patent_app_type] => utility [patent_app_number] => 11/817528 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36307 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111837.pdf [firstpage_image] =>[orig_patent_app_number] => 11817528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5101793 [patent_doc_number] => 20070185055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Method for treating cachexia with retinoid ligands' [patent_app_type] => utility [patent_app_number] => 11/348520 [patent_app_country] => US [patent_app_date] => 2006-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 29721 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185055.pdf [firstpage_image] =>[orig_patent_app_number] => 11348520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5177078 [patent_doc_number] => 20070178138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'Biodegradable non-opthalmic implants and related methods' [patent_app_type] => utility [patent_app_number] => 11/345178 [patent_app_country] => US [patent_app_date] => 2006-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7574 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20070178138.pdf [firstpage_image] =>[orig_patent_app_number] => 11345178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5913601 [patent_doc_number] => 20060128663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Aryl boronate functionalized polymers for treating obesity' [patent_app_type] => utility [patent_app_number] => 11/342129 [patent_app_country] => US [patent_app_date] => 2006-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16304 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128663.pdf [firstpage_image] =>[orig_patent_app_number] => 11342129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 221066 [patent_doc_number] => 07608612 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-27 [patent_title] => 'Radiosensitizer formulations and methods for use' [patent_app_type] => utility [patent_app_number] => 11/336419 [patent_app_country] => US [patent_app_date] => 2006-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 6821 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/608/07608612.pdf [firstpage_image] =>[orig_patent_app_number] => 11336419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705760 [patent_doc_number] => 20060194808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Clinical applications of tetrahydrobiopterin, lipoic acid and their salts and methods of preparing tetrahydrobiopterin bis-lipoate' [patent_app_type] => utility [patent_app_number] => 11/326796 [patent_app_country] => US [patent_app_date] => 2006-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10044 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194808.pdf [firstpage_image] =>[orig_patent_app_number] => 11326796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4746186 [patent_doc_number] => 20080090788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Chemical Compounds' [patent_app_type] => utility [patent_app_number] => 11/794711 [patent_app_country] => US [patent_app_date] => 2006-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12252 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20080090788.pdf [firstpage_image] =>[orig_patent_app_number] => 11794711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5453326 [patent_doc_number] => 20090069363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Therapeutic Agent for Constipation' [patent_app_type] => utility [patent_app_number] => 11/792893 [patent_app_country] => US [patent_app_date] => 2005-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5878 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069363.pdf [firstpage_image] =>[orig_patent_app_number] => 11792893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6547242 [patent_doc_number] => 20100016400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'AZABICYCLIC MUSCARINIC RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 11/719687 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19534 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016400.pdf [firstpage_image] =>[orig_patent_app_number] => 11719687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5913543 [patent_doc_number] => 20060128605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Preventives/remedies for snore or respiratory disturbances during sleep' [patent_app_type] => utility [patent_app_number] => 11/280354 [patent_app_country] => US [patent_app_date] => 2005-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8522 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128605.pdf [firstpage_image] =>[orig_patent_app_number] => 11280354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4873642 [patent_doc_number] => 20080200376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Compositions and Methods For the Treatment Of Obesity and Sexual Dysfunction' [patent_app_type] => utility [patent_app_number] => 11/665127 [patent_app_country] => US [patent_app_date] => 2005-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 32662 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200376.pdf [firstpage_image] =>[orig_patent_app_number] => 11665127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4693087 [patent_doc_number] => 20080085858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'Pharmaceutical Composition' [patent_app_type] => utility [patent_app_number] => 11/576970 [patent_app_country] => US [patent_app_date] => 2005-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10517 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085858.pdf [firstpage_image] =>[orig_patent_app_number] => 11576970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4693143 [patent_doc_number] => 20080085914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'Use Of Organic Compounds' [patent_app_type] => utility [patent_app_number] => 11/576495 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9061 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085914.pdf [firstpage_image] =>[orig_patent_app_number] => 11576495 [rel_patent_id] =>[rel_patent_doc_number] =>)